Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Recent evidence has implicated SLC30A7 in Joubert syndrome based on de novo heterozygous variants observed in two unrelated probands exhibiting classic features including the molar tooth sign, ataxia, oculomotor apraxia, macrocephaly, neurodevelopmental delay, precocious puberty, as well as postaxial polydactyly and accessory oral frenulum (PMID:35751429). In one case, a missense variant, c.407 > C (p.Val136Ala), was identified, while a second case harbored a distinct deletion-insertion variant; both variants affect residues that are highly conserved and were absent from established Joubert syndrome gene panels.
Complementary functional investigations provide further support for the candidate role of SLC30A7. Studies using bimolecular fluorescence complementation confirmed that SLC30A7 can form homodimers and interact with proteins involved in ciliary function, such as TCTN3, thereby offering mechanistic plausibility that disruption of zinc transporter activity may impair ciliary signaling—a hallmark in Joubert syndrome pathology (PMID:24451381). Although the genetic evidence remains limited to two probands, the integration of supportive functional data encourages further consideration of SLC30A7 in diagnostic evaluations for JS.
Gene–Disease AssociationLimitedTwo de novo heterozygous variants identified in unrelated Joubert syndrome probands (PMID:35751429) support a preliminary association. Genetic EvidenceLimitedGenetic evidence comprises two de novo variants (including c.407 > C (p.Val136Ala)) in probands presenting with classic Joubert syndrome features (PMID:35751429). Functional EvidenceModerateFunctional studies demonstrate SLC30A7 homodimerization and its interaction with ciliary proteins such as TCTN3, supporting a role in ciliary signaling (PMID:24451381). |